CIHR Research Projects Funded

Vancouver Prostate Centre investigators were highly successful, receiving 6 Canadian Institutes of Health Research (CIHR) research grants in the Fall 2017 Project Grants competition ( ) for a total of $3.48 million over five years.

The projects funded are listed below.

Ralph Buttyan (co-Is: Artem Cherkasov, Nathan Lack, Na Li): 3 years, $344,250

Interference with Gli to Control Castration Resistant Prostate Cancer

Artem Cherkasov (co-Is: Paul Rennie): 3 years, $459,000

Design and evaluation of small molecules that target the dimerization interface of full-length and splice-variant forms of the androgen receptor as a potential treatment for advanced prostate cancer

Mads Daugaard & William Derry (Hospital for Sick Children, Toronto): 5 years, $1,113,075

Role of alternative polyadenylation in Ras-driven cancers

Xuesen Dong: 5 years, $699,975

RNA splicing regulates prostate cancer progression to hormone therapy resistant neuroendocrine tumors

Martin Gleave & Nathan Lack (co-Is: Artem Cherkasov, Paul Rennie, Robert Young) – Commercialization Project Grant: 2 years, $351,900

Preclinical development of a novel androgen receptor antagonist to treat castration-resistant prostate cancer

Alex Wyatt & Kim Chi: 3 years, $516,375

Predicting therapy resistance in castration-resistant prostate cancer with circulating tumor DNA

Read More

Dr. Martin Gleave is named Member of the Order of Canada

Created in 1967, the Order of Canada, one of our country’s highest civilian honours, recognizes outstanding achievement, dedication to the community and service to the nation. Dr. Gleave  was appointed on December 29th for his research on the mechanisms involved in the propagation of cancer cells and for his leadership in the development of new treatments for prostate cancer.

Read more

Appointments to the Order of Canada

Dr. Elspeth McDougall receives the 2017 Karl Storz Lifetime Achievement Award

Dr. McDougall is the first woman member of the Endourological Society, having joined the society in 1988, and also the first woman to be awarded this prestigious honour. The annual award is given to a senior endourologist whose lifetime contributions have had a major impact on the field of Endourology.

Read more

Dr. Ben Chew receives the 2017 Industry Award for Innovations in Endourological Instrumentation

This award is presented by the Endourological Society to individuals in industry and the company they represent who have promoted Endourology worldwide through product development, support of the society’s foreign fellows program, aided the international distribution of the Journal of Endourology, and/or provided grants in aid for the annual World Congress meeting.

Read more

Dr. Christopher Ong receives the 2017 MSFHR Innovation to Commercialization Award

In the first Innovation to Commercialization Competition, Dr. Christopher Ong received the award for the project title of Development of A Novel Biotherapeutic Fusion Protein Inhibitor For Treatment of Advanced Prostate Cancer.

Read more

Dr. Caigon Du receives the 2017 MSFHR Innovation to Commercialization Award

In the first Innovation to Commercialization Competition, Dr. Caigon Du received the award for the project title of Development of A Novel Organ Preservation Solution in Transplantation.

Read more

Dr. Lynn Stothers is a Primary Recipient of a Wall Scholar Award from the Peter Wall Institute for Advanced Studies

During her time as a Wall Scholar, Dr. Stothers will investigate the ‘mind-body-bladder’ connection in health and disease using novel technology.

Read more

Dr. Martin Gleave receives the Urology Care Foundation 2017 Richard D. Williams, MD Prostate Cancer Research Excellence Award

Since 2013, the Urology Care Foundation has presented the Williams Award, named in honor of the late urologist, scientist, mentor, and humanitarian. The Williams Award is presented annually to an individual (e.g. urologist, scientist, or researcher) for outstanding and impactful research and work in the field of prostate cancer.